logo
Sign in

Azitra Inc.

BRANFORD, CT · Founded 2014 · Biotech · Public

Indian restaurant providing dining services

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · azitra.com

Sector
Biotech
Headquarters
BRANFORD, CT
Founded
2014
Latest Form D
$4.3M, Oct 2022
Total capital
$33.8M
Federal grants
$1.7M
6 awards · 2016–2019
Rank in peer group#10 of 18
Private capital raised
$32.1M
6 Form D · last Oct 2022
48 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
11
29 pending · first 2020
Rank in peer group#1 of 18

Capital timeline

2016201720182019202020212022FEDERAL ↑EQUITY ↓Cumulative $33.8M$150K$150K$225K$225K$225K$720K1st Form D$2.9M4th Form D$17M6th Form D$4.3M
2016201820202022FEDERAL ↑EQUITY ↓Cumulative $33.8M$225K$225K$720K

Latest events

  • Private capital raisedForm D · SEC · 6th filing$4.3M
  • Private capital raisedForm D · SEC · 5th filing$1M
  • Private capital raisedForm D · SEC · 4th filing$17M
  • Federal grantNSF · Phase II · SBIR Phase II: Re-engineered skin bacteria as a novel topical drug delivery system$720K
  • Private capital raisedForm D · SEC · 3rd filing$4.7M
  • Federal grantHealth and Human S · Phase I · Bioengineered skin microbiota for cutaneous mitigation of Netherton Syndrome$225K
  • Federal grantHealth and Human S · Phase I · Bioengineered skin microbiota for cutaneous mitigation of Netherton Syndrome$225K
  • Private capital raisedForm D · SEC · 2nd filing$2.1M
  • Private capital raisedForm D · SEC · 1st filing$2.9M
Show 3 earlier federal awards
  • Federal grantNSF · Phase I · STTR Phase I: Re-engineered skin bacteria as a novel topical drug delivery system$225K
  • Federal grantHealth and Human S · Phase I · Topical application of heterologous protein-expressing Staphylococcus epidermidis for potential therapeutic treatment of skin diseases$150K
  • Federal grantHealth and Human S · Phase I · Topical application of heterologous protein-expressing Staphylococcus epidermidis for potential therapeutic treatment of skin diseases$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

7months

from Azitra Inc.’s first federal award to its first private round.

First federal award · Aug 2016
Health and Human S · $150K
First Form D · Mar 2017
$2.9M · 1st Form D
Awards before first raise
3 awards

An association in public records, not a cause or a prediction.

Standing among 18 peers

Line = median

Biotech · Material

  • Federal grantsBelow median
  • Granted patents#1 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Richard AndrewsResearcherExecutive Officer, DirectorLinked by 1 patent
  • TRAVIS WHITFILLResearcherDirectorLinked by $1.1M in grants as PI
  • Andrew McClaryDirectorNamed in SEC Form D filings
  • Azim MunivarExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • Cain McClaryDirectorNamed in SEC Form D filings
  • Daniel WagnerDirectorNamed in SEC Form D filings
Show all 11 people
  • FRANCISCO SALVAExecutive Officer, DirectorNamed in SEC Form D filings
  • Lucio IannoneDirectorNamed in SEC Form D filings
  • NAVEEN KRISHANDirectorNamed in SEC Form D filings
  • Ricahrd AndrewsExecutive Officer, DirectorNamed in SEC Form D filings
  • STELLA ROBERTSONDirectorNamed in SEC Form D filings

What it has protected

USPTO · 11 granted of 40
Show all 40 patent records

Related companies, and why

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .